title: Terlipressin in patients with septic shock: friend or foe?
authors.forename: M
authors.initials: M
authors.lastname: Westphal
authors.forename: C
authors.initials: C
authors.lastname: Ertmer
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
authors.forename: H-G
authors.initials: HG
authors.lastname: Bone
mesh_terms: D006801:Humans; D008236:Lypressin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000187:drug effects*; D012772:Shock, Septic / Q000188:drug therapy*; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin